- Home
- AFBI vs IKT Comparison
AFBI vs IKT Comparison
Compare AFBI & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- IKT
- Stock Information
- Founded
- AFBI 1928
- IKT 2008
- Country
- AFBI United States
- IKT United States
- Employees
- AFBI N/A
- IKT N/A
- Industry
- AFBI Major Banks
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- AFBI Finance
- IKT Health Care
- Exchange
- AFBI Nasdaq
- IKT Nasdaq
- Market Cap
- AFBI 123.3M
- IKT 123.7M
- IPO Year
- AFBI N/A
- IKT 2020
- Fundamental
- Price
- AFBI $19.26
- IKT $1.54
- Analyst Decision
- AFBI
- IKT Buy
- Analyst Count
- AFBI 0
- IKT 2
- Target Price
- AFBI N/A
- IKT $8.00
- AVG Volume (30 Days)
- AFBI 2.2K
- IKT 98.8K
- Earning Date
- AFBI 10-24-2025
- IKT 11-13-2025
- Dividend Yield
- AFBI 7.79%
- IKT N/A
- EPS Growth
- AFBI 28.43
- IKT N/A
- EPS
- AFBI 1.08
- IKT N/A
- Revenue
- AFBI $31,417,000.00
- IKT N/A
- Revenue This Year
- AFBI N/A
- IKT N/A
- Revenue Next Year
- AFBI N/A
- IKT N/A
- P/E Ratio
- AFBI $17.87
- IKT N/A
- Revenue Growth
- AFBI 4.20
- IKT N/A
- 52 Week Low
- AFBI $17.00
- IKT $1.42
- 52 Week High
- AFBI $22.50
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- AFBI 48.68
- IKT 44.37
- Support Level
- AFBI $18.35
- IKT $1.49
- Resistance Level
- AFBI $19.83
- IKT $1.67
- Average True Range (ATR)
- AFBI 0.11
- IKT 0.10
- MACD
- AFBI -0.10
- IKT -0.00
- Stochastic Oscillator
- AFBI 61.69
- IKT 28.57
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.